InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Wheadon David E., Director. Director active across 6 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 15 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €54k. Activity tracked since 28 May 2021. The latest transaction was disclosed on 16 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Wheadon David E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
39,400 shares0Common StockSEC:0001437749-26-023807:0
10,430 shares0Common StockSEC:0001789507-26-000008:0
5,955 shares0Common StockSEC:0001789507-26-000006:0
1,771 shares@ US$35.3926100.0% of flowOrdinary SharesSEC:0001789507-26-000004:0
Canonical exit: 5 Apr 2026 (T+90)
16,000 shares0Common StockSEC:0001437749-25-020569:0
19,132 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-25-077809:0
16,000 shares0Common StockSEC:0001437749-24-020098:0
20,089 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-24-066020:0
990 shares@ US$330.00100.0% of flowCommon StockSEC:0001140361-24-013935:0
7,375 shares0Common StockSEC:0001437749-23-021501:0
990 shares0Common StockSEC:0000950170-23-029416:0
15,712 shares0Common Stock, $0.01 par value per share (Common Stock)SEC:0001209191-23-033161:0
7,375 shares0Common StockSEC:0001437749-22-019442:0
10,643 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-22-000038:0
9,336 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-21-000044:0
15 of 15 declarations
About Wheadon David E.
David E. Wheadon is a Board Member at Indivior Pharmaceuticals, Inc. and Sotera Health Co. He brings expertise in corporate governance and strategy. His role on the board is essential in guiding the strategic decisions of the companies.
